Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

Komal L. Jhaveri

Breast and Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York

Patrick Neven

Monica Lis Casalnuovo

Hospital María Curie, Buenos Aires

Sung-Bae Kim

Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Eriko Tokunaga

National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan

Philippe Aftimos

Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Brussels

Cristina Saura

Vall d’Hebron University Hospital, Barcelona

Joyce O’Shaughnessy

Baylor University Medical Center, Texas Oncology, U.S. Oncology, Dallas

Nadia Harbeck

Breast Center, Department of Obstetrics and Gynecology and Comprehensive Cancer Center Munich, Ludwig Maximilians University Munich University Hospital, Munich, Germany

Lisa A. Carey

Lineberger Comprehensive Cancer Center, UNC Health, Chapel Hill, NC

Giuseppe Curigliano

Antonio Llombart-Cussac

Hospital Arnau de Vilanova, Valencia, Spain

Elgene Lim

Garvan Institute of Medical Research, Sydney

María de la Luz García Tinoco

Hospital de Oncología, Centro Médico Nacional Siglo XXI, Mexico City

Joohyuk Sohn

Yonsei Cancer Center, Seoul, South Korea

André Mattar

Mastology Department, Women’s Health Hospital, São Paulo

Qingyuan Zhang

Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, China

Chiun-Sheng Huang

National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei

Chih-Chiang Hung

Division of Breast Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan

Jorge Luis Martinez Rodriguez

Filios Alta Medicina, Monterrey, Mexico

Manuel Ruíz Borrego

Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain

Rikiya Nakamura

Department of Breast Surgery, Chiba Cancer Center Hospital, Chiba, Japan

Kamnesh R. Pradhan

Eli Lilly, Indianapolis

Christoph Cramer von Laue

Eli Lilly, Indianapolis

Emily Barrett

Eli Lilly, Indianapolis

Shanshan Cao

Pingyuan Laboratory, School of Chemistry and Chemical Engineering

Xuejing Aimee Wang

Eli Lilly, Indianapolis

Lillian M. Smyth

Eli Lilly, Indianapolis

François-Clément Bidard

Institut Curie, Paris and Saint-Cloud; INSERM Centre d’Investigation Clinique 1428, Paris; Versailles–Saint-Quentin University, Paris–Saclay University, Saint Cloud, France